XML 28 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
U.S. Initial Public Offering on Nasdaq (Details)
$ / shares in Units, $ in Millions
 6 Months Ended
Jun. 06, 2022
ILS (₪)
Jun. 06, 2022
USD ($)
Jun. 30, 2022
ILS (₪)
shares
Jun. 30, 2022
$ / shares
shares
Dec. 31, 2021
shares
U.S. Initial Public Offering on Nasdaq (Details) [Line Items]          
Received gross proceeds amount ₪ 43,441,000 $ 13      
Number of units     2,941,918    
Public of per unit (in Dollars per share) | $ / shares       $ 4.13  
Warrant exercisable description     (i) one ADS and (ii) one Warrant exercisable for one ADS over a limited period of 5-years from the issuance date at an exercise price of $5.00 (the warrants are subject to a cashless exercise mechanism upon under certain events) and    
Number of pre-funded units     208,282    
Public of per pre-funded unit (in Dollars per share) | $ / shares       $ 4.129  
Pre-funded warrant exercisable description     (i) one pre-funded warrant exercisable for one ADS over unlimited period at an exercise price of $0.001 (the pre-funded warrants are subject to a cashless exercise mechanism upon under certain events) and (ii) one warrant exercisable for one ADS over a limited period of 5-years from the issuance date at an exercise price of $5.00 (the warrants are subject to a cashless exercise mechanism upon under certain events).    
Issue ordinary shares       22,694,296 7,984,706
Purchase to additional shares     126,482    
Public price per shares (in Dollars per share) | $ / shares       $ 4.129  
Warrants exercisable shares     157,510    
Exercise price (in Dollars per share) | $ / shares       5.16  
Over a limited period     5 years    
Over-allotment option has been expired     343,172    
Warrants descriptions     As the Over-Allotment Option exercisable for ADS, Over-Allotment Option exercisable for pre-funded warrants and/or warrants and the Representative’s Warrant were granted to the underwriter as compensation for its underwriting services rendered in respect to the U.S. IPO, they were accounted for under IFRS 2 “Share-based Payment” in total amount of NIS 5, NIS 588 and NIS 461, respectively.    
Share based pay (in New Shekels) | ₪     ₪ 461    
Expected dividend yield rate     0.00%    
Expected volatility     52.92%    
Warrants per share (in Dollars per share) | $ / shares       0.3508  
Total incremental and direct issuance costs amounted (in New Shekels) | ₪     ₪ 7,949    
Allocated to warrants amount (in New Shekels) | ₪     723    
Pre-funded warrants amount (in New Shekels) | ₪     ₪ 7,226    
Over Allotment Option [Member]          
U.S. Initial Public Offering on Nasdaq (Details) [Line Items]          
Purchase to additional shares     469,654    
Warrants exercisable shares     469,654    
Exercise price (in Dollars per share) | $ / shares       $ 0.001  
Bottom of range [member]          
U.S. Initial Public Offering on Nasdaq (Details) [Line Items]          
Risk-free interest rate     2.16%    
Top of range [member]          
U.S. Initial Public Offering on Nasdaq (Details) [Line Items]          
Risk-free interest rate     (3.11%)    
Ordinary shares [member]          
U.S. Initial Public Offering on Nasdaq (Details) [Line Items]          
Issue ordinary shares       5